Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
| Role | Insider | Date | Transaction | Value | Shares |
|---|---|---|---|---|---|
| CFO | Ma Stephen Hoi | Apr 17, 2026 | Buy | $99.97K | 650,000 |
| CEO | Ji Henry | Apr 17, 2026 | Sell | $99.97K | 650,000 |
| CEO | Ji Henry | Apr 16, 2026 | Buy | $499.85K | 3,250,000 |
| 10% Owner | Scilex Holding Co | Dec 30, 2025 | Sell | $5.21M | 9,657,300 |
| 10% Owner | Scilex Holding Co | Dec 29, 2025 | Sell | $4.79M | 7,310,984 |
| 10% Owner | Scilex Holding Co | Dec 26, 2025 | Sell | $2.77M | 3,689,016 |
| Director | SHAH JAISIM | Dec 18, 2024 | Buy | $13.8K | 30,000 |
| Chairman | Ji Henry | Oct 31, 2024 | Buy | $8.35K | 8,888 |
| Director | SHAH JAISIM | Oct 29, 2024 | Buy | $31.67K | 32,000 |
| Director | Chun Jay | Oct 18, 2024 | Buy | $4.75K | 5,000 |
| Director | Followwill Dorman | Oct 18, 2024 | Buy | $990 | 1,000 |
| Chairman | Ji Henry | Oct 17, 2024 | Buy | $9.71K | 10,000 |
| Director | Lemus David | Oct 17, 2024 | Buy | $1.8K | 2,000 |
| Director | Wu Yue Alexander | Oct 17, 2024 | Buy | $18.99K | 20,000 |
| CFO | Ma Stephen Hoi | Oct 16, 2024 | Buy | $6.5K | 6,700 |
| Director | SHAH JAISIM | Oct 16, 2024 | Buy | $29.75K | 30,000 |
| CFO | Ma Stephen Hoi | May 17, 2024 | Buy | $12.44K | 14,140 |
| Chairman | Ji Henry | May 17, 2024 | Buy | $43.99K | 50,000 |
| Director | Chun Jay | May 17, 2024 | Buy | $51.64K | 57,500 |
| Director | SHAH JAISIM | May 17, 2024 | Buy | $52.1K | 56,939 |
| Director | SHAH JAISIM | May 16, 2024 | Buy | $69.85K | 83,061 |
| 10% Owner | Sorrento Therapeutics, Inc. | Sep 21, 2023 | Sell | - | 60,068,585 |
| 10% Owner | Sorrento Therapeutics, Inc. | Sep 21, 2023 | Sell | - | 4,490,617 |
| 10% Owner | Sorrento Therapeutics, Inc. | Dec 2, 2022 | Buy | $78.85K | 224,841 |
| 10% Owner | Sorrento Therapeutics, Inc. | Nov 25, 2022 | Buy | $20.2K | 46,172 |
Open-market purchases and sales reported on SEC form 4 over the last 10years. Awards, option exercises, gifts and other non-market form 4 activity are excluded. Chart markers group a day's filings by direction; the table lists each filing.